EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Electro Acupuncture is not Recommended for Managing Chronic Neuropathic Pain in Chemotherapy Induced Peripheral Neuropathy: A Double Blind Randomized Controlled Trial

Journal of Orthopedic Research and Therapy · 2022

DOI: 10.29011/2575-8241.001266 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Orthopedic Research and Therapy, 2022. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Research on acupuncture treatment for Chemotherapy Induced Peripheral Neuropathy (CIPN) lack important scientific standards that include homogenous populations, sham control groups, and valid and reliable outcome measures.This prospective double-blind Randomized Controlled Trial (RCT) sought to answer whether Electro Acupuncture (EA) could improve chronic neuropathic CIPN pain in breast cancer patients exposed to taxane chemotherapy compared to a sham acupuncture control group.

Methods

18 participants were recruited from the cancer registry at CancerCare Manitoba.The primary outcome measure was the Numeric Pain Rating Scale (NPRS).Subjective questionnaires and Quantitative Sensory Testing (QST) were used to establish nerve pain and function for baseline and follow up post 6-week trial.Acupuncture treatment consisted of bilateral points LR3, LI4 and ST36 with EA at 2Hz at maximum tolerance bilaterally x 30 minutes, once a week over 6 weeks.Sham acupuncture using Streitberger Placebo Needles (Asiamed) included the same points and treatment parameters.

Results

Baseline NPRS scores were equal between the groups with sham median (Q1-Q3) 5.5 (4.75-6.0)and true 5.0 (3.5-7.75)NS.Post pain scores revealed a statistically significant and clinically relevant improvement for the sham group with a reduction in pain to 2.50 (2.0-3.0),p=0.04 compared to the true EA group 4.25 (3.25-5.0)that demonstrated no clinical or statistical improvement.

Conclusion

This trial used best practice, incorporated a homogeneous population, used valid and reliable outcome measures, and sham controls.The evidence suggests that EA does not provide superior analgesia compared to placebo acupuncture and may reduce the placebo response.

Zitieren

APA

(2022). Electro Acupuncture is not Recommended for Managing Chronic Neuropathic Pain in Chemotherapy Induced Peripheral Neuropathy: A Double Blind Randomized Controlled Trial. Journal of Orthopedic Research and Therapy. https://doi.org/10.29011/2575-8241.001266

Vancouver

Electro Acupuncture is not Recommended for Managing Chronic Neuropathic Pain in Chemotherapy Induced Peripheral Neuropathy: A Double Blind Randomized Controlled Trial. Journal of Orthopedic Research and Therapy. 2022. doi:10.29011/2575-8241.001266

BibTeX
@article{euvimed2022,
  title = {Electro Acupuncture is not Recommended for Managing Chronic Neuropathic Pain in Chemotherapy Induced Peripheral Neuropathy: A Double Blind Randomized Controlled Trial},
  journal = {Journal of Orthopedic Research and Therapy},
  year = {2022},
  doi = {10.29011/2575-8241.001266}
}
Kostenlos starten →